Psoriasis is an autoimmune condition characterized by red and scaly patches of skin that can be itchy, painful, and embarrassing. Treatment options range widely, from topical treatments to phototherapy and systemic medications such as Xeljanz.
Xeljanz is a janus kinase (JAK) inhibitor, which works by blocking the chemical signals that cause the skin inflammation associated with psoriasis. In clinical trials of patients with active psoriasis, Xeljanz was able to reduce the severity of symptoms and improve quality of life for many patients. Some studies have also found that Xeljanz is effective in treating alopecia areata, an autoimmune condition that causes patchy hair loss on the scalp.
The safety of Xeljanz has also been studied. So far, side effects of the medication such as bleeding, infections, and liver problems have been rare in clinical trials. The most common side effect
Article Created by A.I.